The ATXA team has strong expertise in cardiovascular and cancer biology with technical know-how in platelet biology, cellular and molecular biology, protein biology, pathological and histopathological and immunohistochemical techniques, digital pathology and biostatistics.

 

In addition, ATXA’s team has extensive experience in drug discovery; lead optimization; candidate selection; medicinal chemistry; preclinical - and clinical-stage drug development; IP management and commercialization.